Mirae Asset Global ETFs Holdings
RVMD icon

Mirae Asset Global ETFs Holdings’s Revolution Medicines RVMD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.81M Buy
40,628
+36,252
+828% +$3.66M 0.01% 907
2025
Q4 		$349K Sell
4,376
-4,820
-52% -$316K ﹤0.01% 2077
2025
Q3 		$424K Buy
9,196
+1,724
+23% +$67.5K ﹤0.01% 1944
2025
Q2 		$276K Sell
7,472
-101,532
-93% -$3.9M ﹤0.01% 2113
2025
Q1 		$3.87M Buy
109,004
+6,877
+7% +$279K 0.01% 841
2024
Q4 		$4.46M Buy
102,127
+12,084
+13% +$610K 0.01% 804
2024
Q3 		$4.08M Buy
90,043
+13,093
+17% +$570K 0.01% 832
2024
Q2 		$2.98M Buy
+76,950
New +$2.88M 0.01% 925

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return